Both in Biotechnology
Cullinan Therapeutics vs Solid Biosciences
Over the past year CGEM returned +47.7% and SLDB returned +57.3%; their daily moves had a correlation of 0.35.
CGEM +47.7% SLDB +57.3%Growth of $1, one year, split-adjusted
| Metric | CGEM | SLDB |
|---|---|---|
| Price | $10.80 | $6.18 |
| Market cap | $695.0M | $662.7M |
| Today | −13.53% | −5.21% |
| 1 month | −30.9% | −9.8% |
| 6 months | −26.6% | −12.6% |
| Year to date | +4.3% | +9.6% |
| 1 year | +45.9% | +40.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $334.5M | $377.7M |
| Dividend yield | — | — |
| Volatility (60d) | 92.0% | 68.9% |
| Short % of float | 14.3% | 17.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).